Wu CE, Chang CF, Huang CY, Yang CT, et al. Feasibility and effectiveness of afatinib for poor performance status patients with EGFR-mutation-positive non-small-cell lung cancer: a retrospective cohort study. BMC Cancer 2021;21:859.
PMID: 34315431